NCT00000896View on ClinicalTrials.gov

A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

October 31, 2000

Conditions

HIV Infections

Interventions

DRUG

Indinavir sulfate

DRUG

Lamivudine/Zidovudine

BIOLOGICAL

Hepatitis A Vaccine (Inactivated)

DRUG

Interleukin-12

DRUG

Nevirapine

DRUG

Stavudine

DRUG

Sargramostim

Trial Locations (3)

80262

University of Colorado Hospital CRS, Aurora

Unknown

Ucsd, Avrc Crs, San Diego

Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000896 - A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients | Biotech Hunter | Biotech Hunter